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CHAPTER I 
 
 
INTRODUCTION 
 
Hydrogen peroxide (H2O2), a reactive oxygen species, is capable of causing 
damage to cellular components, such as DNA, proteins, and lipids (36, 49, 81). This 
compound is found in all living cells undergoing aerobic respiration, as redox reactions 
take place. Normally, aerobic microorganisms are protected from the cytotoxic effect of 
H2O2 by the enzyme catalase which neutralizes it to oxygen and water, but Streptococcus 
pneumoniae does not encode for catalase (81). Involvement of H2O2 together with 
pneumolysin, a cytolysin enzyme, in virulence has been shown to mediate pneumococcal 
meningitis (13).  
 
Production of H2O2 by pyruvate oxidase (SpxB) in S. pneumoniae can reach 
millimolar levels, which is 103-fold higher than the concentration required for inhibiting 
Escherichia coli growth and capable of extending toxic effects on many other species of 
bacteria and even eukaryotic cells (13, 79, 81). In a H2O2 sensitivity test, DP1004, an Rx1 
strain of S. pneumoniae, showed a 10-fold increased resistance to H2O2 when pregrown 
in lactose than when compared to other sugars (Fig. 1). The mechanisms by which S. 
pneumoniae is able to demonstrate resistance to both endogenously generated H2O2 and 
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lactose-induced protection to H2O2 are unknown. H2O2 resistance has been shown to 
depend on the spxB gene, and its enzymatic activity (81). Other H2O2 protective protein 
homologs, found by amino acid homology studies, such as thioredoxin reductase (trxB), 
glutathione reductase (gor), glutathione peroxidase (basA), and glyoxalase (spr0643) 
were identified, but the function of each has not been determined. Nicotinamide adenine 
dinucleotide oxidase (nox) has been shown to confer protection to the bacterium from 
oxidative stress by reducing O2 to H2O (4, 81). Mutation of spxB abolishes H2O2 
resistance, even in a lactose pregrown mutant, demonstrated by the H2O2 sensitivity test 
(118). The Mechanism of catabolite-regulated gene expression in S. pneumoniae is 
shown to have very similar properties to enteric Gram negative bacteria, the lac operon 
(71, 107). Catabolite-activator protein (CAP of E. coli) or catabolite control protein (CCP 
of S. pneumoniae) are DNA-binding proteins governing transcription of catabolic 
operons. The present study was designed to determine several aims: 
 
Aim I: Analysis of possible mechanism of lactose-regulated H2O2 resistance 
 
I. Does the CCP protein regulate the expression of both lac operon as well as the 
H2O2 resistance genes?  
II. What co-factor activates the CCP or a protein with a similar function? 
III. Which genes are involved in the H2O2 resistance? 
 
Aim II: Genetical analysis of spxB 
I. Does pneumococcal SpxB-mediated H2O2 resistance have a correlation with 
the H2O2 production? 
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II. Do any of the catabolite-regulated genes affect the H2O2 production?  
III. Does catabolite regulation play a role in SpxB-mediated H2O2 resistance? 
IV. What are the factors that regulate SpxB’s activity? 
 
Grown in % survival 
Lactose 17.65 ± 2.47 
Galactose 1.14 ± 0.59 
Glucose 1.15 ± 0.74 
Fructose 1.36 ± 0.74 
Maltose 1.46 ± 0.59 
Mannose 1.66 ± 0.74 
Xylose 1.90 ± 0.93 
Sucrose 1.96 ± 1.05 
 
Figure 1. Effect of exogenous H2O2 on pneumococcal cells grown in various carbohydrates. Pneumococcal 
wild-type cells were grown microaerobically in various sugars shown above in CATPSugar at 37˚C. At 
OD550 = 0.1, the cells were treated with 10 mM exogenous H2O2 and incubated at 37˚C for 30 min before 
plating on CATPGlu agar plates. Survival was given in percentage (% survival rate). An equal volume of 
sterile water as in 10 mM H2O2 was used to treat cells for a control (118). 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
S. pneumoniae, discovered more than 100 years ago, is one of the earliest-known 
human pathogens (45). DNA, as the genetic material of all living things, was first 
determined in this bacterium by Avery’s group (5). This Gram positive, lancet-shaped, 
aero-tolerant diplococcus, commonly known as pneumococcus, is a member of the lactic 
acid bacteria (1, 81). The sequenced genome, 2.04 mega bases in length, is composed of 
low G-C, and has allowed the identification of several virulence factors by homology 
comparison to other pathogens (46). S. pneumoniae is the major cause of otitis media, 
pneumonia, bacteremia, and meningitis in immuno-compromised hosts (13, 53, 81, 86, 
117). S. pneumoniae is harbored inside hosts of all ages in the nasopharynx. Around 5 
million children worldwide under the age of 5 are killed annually by pneumonia, with S. 
pneumoniae being the leading cause of death (53). Otitis media caused by this bacterium 
is also common around 5 years of age with approximately 7 million cases annually in the 
United States. There are about 50,000 cases of bacteremia and 3000 cases of meningitis 
found annually in the US (53). Together, this pathogen is recognized as the main cause of 
death in the United States compared with any other bacterial pathogen (53). 
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Pathogenesis of S. pneumoniae 
 
Many proteins or enzymes involved in the pathogenesis of Gram-positive 
pathogens are found on the cell surface (53).  Even though advanced instruments 
available in genomic study have allowed the identification of many virulence factors, the 
full picture of the mechanism involved in pneumococcal pathogenesis has still yet to 
emerge, and allow a greater understanding of the deadliest human pathogen (53).  
 
Some cell surface proteins of S. pneumoniae, capable of causing virulence to the 
pathogen, identified by antibody recognition, are pneumococcal surface protein (pspA), 
hyaluronate lyase (hyl), autolysin (lytA amidase), pneumolysin (ply), and neuraminidase 
(nanA or nanB). 
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Capsule 
 
Protection of S. pneumoniae by the capsule, a compound of polysaccharides 
found outside of the pneumococcal cell wall, from human phagocytosis renders this 
pathogen clinically important (1, 2, 47). Encapsulated strains are found to require a lower 
dose (50%) of bacteria for disease development in the host than the non-encapsulated 
strains; furthermore, capsulated strains are much more virulent than their counterpart 
(111). Currently, there are more than 90 serotypes of pneumococcal capsule, which have 
been determined to have no cross immune-reactivity between each other (97). 
Pneumococcal cells are protected from phagocytosis by the capsule which blocks the host 
complement system from accessing the bacterial cell wall (1, 2, 47). Capsules of various 
types have been shown to be associated with different degrees of virulence (57). 
Virulence of S. pneumoniae has also been shown to depend on the presence of other 
genetic background which together contributes to the full pathogenesis of S. pneumoniae 
(57). 
   
 Pneumococcal surface protein A 
 
The PspA enzyme (67 – 99 kDa) is found on the cell wall of the bacterium. It 
stabilizes the capsule, and has structural and antigenic variability among different 
pneumococcal strains (52). The compound protects the pathogen from host phagocytosis 
and C3-mediated of complement clearance (14). The presence of this protein homolog in 
other microbes, such as Streptococcus pyogenes, Plasmodium falciparum, Enterococcus 
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faecalis, and Staphylococcus aureus, likely offers a similar defense mechanism to these 
bacteria (53). 
 
Pneumococcal surface antigen A 
 
PsaA enzyme (~37 kDa) is present on the cell wall of the bacterium (A). 
Attenuation of pspA has been shown to confer avirulence to the mutant in both 
intraperitoneal and intranasal challenges model (11). Sequence analysis suggests that 
PspA belongs to the family of ABC-transporter, and it is responsible for the uptake of 
Zn2+ and Mn2+ into a pneumococcal cell, suggesting possible role of the ions in 
pneumonoccal virulence. This observation was confirmed by the findings that Mn2+ is 
required by pneumococcal superoxide dismutases (SOD), to detoxify hydrogen peroxide 
made during aerobic growth by the bacterium, as well as to induce other pneumococcal 
virulence related genes (55, 88). On the other hand, the role of Zn2+ is not clearly known. 
Low concentration of Zn2+ in both the femur and the plasma of mice treated with no Zinc 
in the diet was shown to lead to a reduced response to the PsaA antigen in the mice, 
resulting to high risk of pneumococcal infection and death (101). Amino acid sequence 
analysis has shown homology with putative fimbrial adhesions of Streptococcus sanguis 
and Streptococcus parasanguis (11).  
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Hyaluronate lyase 
 
Hyl enzyme (107 kDa) is a surface protein, and it belongs to a broader group of 
enzymes known as hyaluronidases. Full virulence of S. pneumoniae requires the presence 
of this enzyme. Activation of Hyl by Ca2+ causes degradation of hyaluronan which is part 
of the extracellular matrix components (60, 84, 85); consequently, this enzyme promotes 
tissue permeability for pneumococcal invasion (57). In addition this enzyme is also 
present as a released compound, and is suggested to facilitate endolysis and promote 
pneumococcal invasion to the host (9, 53). Hyaluronan has been shown to have 
connections with many biological processes like fertilization, embryonic development, 
cell migration, differentiation, wound healing, inflammation, growth, metastasis of tumor 
cells and defense mechanisms (53, 105, 110). Homologs of this protein are found in S. 
aureus, Propionibacterium acnes, and Streptococcus agalactiae, which are also known 
human pathogens (53, 82, 83).  
 
Neuraminidase 
 
This enzyme is present in different forms (NanA 107 kDa, NanB 75 kDa), and is 
located on the surface of pneumococcal cells (15). The different sizes of neuraminidase 
favor a certain pH for the enzymatic activity; NanA pH 7, NanB pH 5 (10). It cleaves 
sialic acid from the host cell surface glycans, such as mucin, glycolipids, and 
glycoproteins (53). The role of neuraminidase is suggested to enhance colonization of 
this bacterium by exposing the host cell due to the cell structure degradation, but it is yet 
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to be determined (58, 61, 91). A protein homolog is found in Salmonella enterica serovar 
Typhimurium although it has less than 50% amino acid similarity (53). 
 
Autolysin  
 
Autolysin is common in all bacterial cells. It is responsible for degradation of 
bacterial peptidoglycan during cell growth, turn over, and cell separation (89, 108). In a 
middle ear infection test with a chinchilla otitis media model, this enzyme was shown to 
play a major role in causing otitis media (93). Virulence of this enzyme is connected to 
its ability to release a cytoplasmic cytolysin, the pneumolysin (54, 69). Under laboratory 
conditions, pneumococcal autolysin enzyme, N-acetylmuramoyl-L-alanine amidase (~36 
kDa), encoded by lytA, is found to cause autolysis during stationary phase and 
competence development. In addition, lysozyme, a host defensive component, is shown 
to enhance autolysin production and promote release of pneumolysin (1, 69). 
 
Pneumolysin 
 
Pneumococcal Ply (53 kDa) is a cytoplasmic enzyme found in all clinical 
pneumococcal strains known today (73, 74, 75). It is a choresterol-dependent cytolysin 
(53). The steps of cytolysis by this enzyme include, binding to the host cell cytoplasmic 
membrane choresterol, inserting into the membrane, and then, pore formation. As a 
result, target cells can range from ciliated bronchial epithelial cells to pulmonary 
endothelial cells. These cells undergo lysis, causing pneumonia and bacteremia (53, 87, 
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92, 100). In addition, it is also found to be toxic to phagocytes and immune cells, 
resulting in a compromised immune system and pathogenic infection (53). Protein 
homologs are found in Clostridium perfringens, Aeromonas hydrophilia, Staphylococcus 
aureus, and Bacillus anthracis (53).   
 
Phase variation 
  
Different ecological characteristics of S. pneumoniae are determinded by the 
niches in the host which are different by oxygen levels. The human nasopharynx is highly 
aerated, while most of the other sites provide an anaerobic environment. In order to adapt 
to the different conditions in the host during infection, this bacterium carries out the 
process of phase variation. The difference in phases has been corresponded to variations 
in the colony morphology (opaque or transparent), and the transparent variant has been 
connected with an increased ability to attach to the human nasopharynx, vascular 
endotheliar cells, and cytokine-stimulated type II lung cells (113). Consequently, the 
bacterium proliferates and increased bacterial density is found at the site of attachment. 
On the contrary, the opaque variant is found to be more adaptable and cause systemic 
infections after intraperitoneal inoculation into mice (114).   
 
Treatment of infections due to pneumococcus 
 
Pneumococcal infection is commonly treated by Beta-lactam antibiotics. 
Currently, the bacterium is becoming more difficult to treat, mainly due to some 
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pneumococcal strains that have gradually gained resistance to antibiotics (7, 22, 23, 76). 
Efforts to explore different ways to treat pneumococcal infections, such as vaccines 
derived from pneumococcal surface proteins, recognized by the surface enzyme signature 
sequence LPXTG (15, 34, 35, 94), are on going (8, 10, 12, 53, 65). Even though the 
number of vaccines has increased by ~50% since 1983, vaccination is ineffective for 
children younger than 2 years due to a poor immunologic response (53). In addition, 
conjugate vaccines, developed by chemically linking bacterial polysaccharides to an 
enzyme, have provided a protection to all recipients, but it still shows limitation because 
S. pneumoniae occasionally goes through modification of the capsule and the high 
production costs of vaccine (45, 64).  
 
Mechanisms of catabolite regulated gene expression in other bacteria 
 
To date, the role of sugar in pneumococcal pathogenesis is not clearly known. 
However, the mechanisms of gene regulation governed by sugar have been illustrated in 
other bacteria.  
 
CAP in Escherichia coli, lac operon 
 
A well studied mechanism where gene expression is regulated by carbohydrate 
metabolism is available in E. coli. In this bacterium, the gene regulation is governed by 
the phosphate-transferase system (PTS). This multi-enzyme complex system distributes 
part of the enzymes on the cell surface of the bacterium. Attachment of a speci
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these surface enzyme receptors triggers cellular activities to take place and regulate 
transcription of the lac operon. In brief, the PTS enzyme IIAGlc activates adenylate 
cyclase by phosphorylation; consequently, it catalyzes production of the cyclin adenine 
monophosphate (cAMP). The cAMP is then bound with a catabolite-activator protein 
(CAP, equivalent to CCP) to form the cAMP-CAP complex. Subsequently, the complex 
binds to CAP region located upstream of promoter of the lac operon. As a result, an 
interaction between cAMP-CAP complex and RNA polymerase takes place, and this is 
found to enhance transcription of the operon (59, 78, 107).   
 
CCP in Gram-positive bacteria  
 
However, in the low G-C Gram-positive bacteria, it is slightly different. In the 
presence of lactose, the PTS serves as the major transporter to bring lactose in, and does 
not have IIAGlc, and cAMP is found to activate transcription of the lac operon. In this 
system, a non-lactose carbohydrate allows phosphorylation of the Histidine-containing 
phosphocarrier protein (HPr) at the serine residue, HPr (Ser-P) by HPr 
kinase/phosphorylase. The HPr (Ser-P) is then bound with a Ccp to form the complex 
HPr (Ser-P) – Ccp. Subsequently, this complex then binds to the catabolite-responsive 
element (cre, equivalent to CAP), located at upstream of the promoter region of the lac 
operon and this is found to prevent transcription of the operon (59, 78, 107).  
 
Together, the information suggested that there are catabolic operons that are 
responsible for H2O2 resistance in S. pneumoniae, and transcription of the catabolic 
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operons could be regulated by the same mechanism.  
 
Pyruvate oxidase (spxB) as one of the virulence factors in S. pneumoniae 
 
This 1.8 kb gene is shown to be present in S. pneumoniae in a monocistronic 
operon by Northern blots (81, 19). A homologous study by amino acid alignment did not 
show any match to E. coli enzymes. It is the major H2O2-producing agent in S. 
pneumoniae (81). 
 
H2O2 production by SpxB 
 
As a nasopharyngeal inhabitant, S. pneumoniae possesses the enzymes lactate 
oxidase (Lox) or SpxB to protect the cells from the oxidative toxicity (43, 81, 104). In the 
aerobic condition, the bacterium is shown to have higher spxB gene expression and more 
endogenous H2O2 production (81, 16, 96). The amount of acetyl-phosphate is also 
increased by the enzymatic process performed by the enzyme SpxB, which will be 
converted to ATP by the acetate kinase in the presence of acetate (81, 104). 
 
O2 + pyruvate + Pi  -----------------> CO2 + H2O2 + acetyl-phosphate 
 
 
 
 
 14
SpxB-mediated colonization in pneumococcus 
 
Colonization is required for invasion, transmission, and genetic manipulation of S. 
pneumoniae (42). The production of H2O2 by S. pneumoniae is suggested to have an 
inhibitory effect on its commensal flora (79). A knock-out mutation of spxB shows 
reduced virulence for nasopharyngeal colonization, pneumoniae, and bacteremia (7, 86, 
99). The mechanism of spxB in colonization is not completely known. Phase variation 
has been shown to have an association with the H2O2 production by the bacterium; 
therefore, suggesting a larger network of pathways that may involve adaptation and the 
colonization of S. pneumoniae, and mutation of spxB has been shown to have a defect on 
the phase variants (80, 86). Maximum expression of spxB occurs during the early growth 
phase, and this corresponds with the time of pneumococcal competence (7, 62). 
 
Modulation of cell competence by SpxB 
 
Natural transformation is found in at least 40 bacterial species, and it is present in 
S. pneumoniae (66). Manipulation of DNA by this process has allowed the emergence of 
penicillin-resistant pneumococcal isolates and switching of capsules (22, 23, 76). 
Pneumococcal competence is induced by competence-stimulating peptide (CSP); 
consequently, it causes DNA uptake as well as DNA release (7, 70, 21). Activation of 
competence is a two-component signal transduction process, and the O2 sensor ciaRH is a 
DNA-binding response regulator (4, 24, 37, 40). When O2 is absent, this enzyme is 
thought to activate the protease HtrA and cleaves the CSP to down-regulate the 
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pneumococcal competence (24, 95).  In addition, another O2 sensor NADH oxidase (nox) 
is suggested to also play a role in the competence, and it optimizes the results of 
pneumococcal competence (4, 30, 116). The mechanism of cell lysis and the release of 
DNA due to the competence remains to be resolved. Mutation of the spxB reduces 
transformability and the ability of S. pneumoniae to release DNA, suggesting H2O2 is 
involved in the DNA release (7). Expressions of the competence-specific genes comC 
and recA are shown to have a reduced RNA level determined by real-time RT-PCR (7). 
In summary, factors that governing pneumococcal competence have been expanded to 
not only involve the enzymes CiaRH, HtrA, ComC, RecA, and Nox but also the enzyme 
SpxB. However, the mechanisms connecting spxB gene with competence remain to be 
explored.  
 
H2O2 resistance by SpxB 
 
During nasopharyngeal colonization, the amount of H2O2 production by S. 
pneumoniae may reach milimolar, and it is thought to confer an inhibitory effect on the 
competitive commensal flora (79). In addition, as mentioned before, H2O2 is thought to 
play a role in pneumococcal meningitis by inducing brain cell apoptosis (13). The 
mechanism by which S. pneumoniae resists the high amount of endogenous H2O2 is still 
not clearly known. Pericone et al. (81) showed that a spxB-deficient mutant exhibits 
reduced virulence for exogenous H2O2 resistance, and it is shown to have a correlation 
with H2O2 production. On the contrary, Rx1 cells pregrown in lactose are shown to have 
much higher resistance (at least 3-fold) to H2O2 challenged exogenously than any other 
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sugars tested (118). As mentioned before, there are many enzyme homologues, which 
serve to protect other bacteria from oxidative stress, that are also found in S. pneumoniae, 
but there is yet to be any experimental evidence that shows the function of the enzyme 
homologues. The NADH oxidase (nox) is also present in Streptococcus mutans. Its 
function is to protect the cells from oxidative toxicity, and it is shown to affect the 
transformability S. pneumoniae (29, 43). Attenuation of the spxB gene also affected the 
persistence of S. pneumoniae in the host.  
  
Together, the pathway of pneumococcal competence is complicated, and it is 
regulated at least by CiaRH, HtrA, ComC, RecA, Nox, and SpxB. In addition, the role of 
spxB in H2O2 resistance is unclear, and determination of the relationship between H2O2 
resistance and sugar metabolism is a pioneering work. The following studies were 
performed to investigate whether the lactose-regulated H2O2 resistance of S. pneumoniae 
has any effect on the induction of gene, and characterization of lactose-induced genes for 
H2O2 resistance was carried out. It is shown that in strain Rx1 (2), random mutagenesis of 
the chromosomal DNA showed induced gene expression as well as reduced H2O2 
resistance in some of the isolates. This work was continued to determine the relationship 
between all the H2O2 resistance genes and the spxB by measuring levels of the H2O2 
production. In addition, determination of other factors that regulate spxB activity was also 
carried out by measuring levels of H2O2 production. 
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CHAPTER III 
 
 
METHODOLOGY 
 
Bacterial strains and growth conditions. 
  
  
Bacterial strains and plasmids used in the present study are listed in Table 1. To 
culture pneumococcal cells, casein hydrolysate (CAT) medium was used. It was prepared 
by dissolving 1% casein, 0.5% tryptone, 0.5% NaCl, and 0.1% yeast extract in one liter 
of distilled water, and sterilized by autoclaving.  Unless otherwise stated, glucose and 
K2HPO4 were then added to yield a final concentration of 11 mM and 16 mM, 
respectively. This medium is now called CATPGlu. To make CAT agar media, 1.5% 
(W/V) of agar powder (DIFCO BiTekTM AGAR) was added. Unless otherwise specified, 
pneumococcal cells were grown in a 13 mm slip cap tube using 1% of pneumococcal 
cells (at OD550 = 0.2) in CATPGlu broth, supplemented with a selective drug at suggested 
concentration demonstrated in Table 3, and incubated at 37ºC under ambient light. This 
provides a microaerobic growth condition. The growth of cells was monitored by 
measuring the turbidity with a spectrophotometer (Spectronic 20). CATP was used as the 
blank solution to obtain the actual reading of the turbidity. Pneumococcal cells grown to 
OD550 = 0.2 were supplemented with 10% sterile glycerol (V/V) in a 16 mm screw cap 
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tube to be stored at -80ºC. To study spxB, both microaerobic and aerobic conditions were 
used to grow in the flasks 125 ml, 250 ml, or 500 ml, which ever appropriate to contain 
the culture volume needed for the experiment. Aerobic growth conditions were obtained 
by using a shaker (New Brunswick Scientific) at 200 rotations per minute (r.p.m.). For 
the studies that required dark and aerated conditions, the window on the top of the shaker 
was covered with a piece of aluminum foil. Microaerobic and dark conditions were 
provided using a 37ºC incubator (VWR I530). Unless otherwise noted, pneumococcal 
cell density was assessed using the overlay method. Bacterial cells were transferred to 4 
ml CATPGlu broth in a 16 mm cap tube containing 1/20 of 4% bovine serum albumin 
(BSA), vortexed to mix the contents, mixed with 4 ml of molten CATPGlu agar, kept in a 
13 mm slip cap tube in the same 16 mm cap tube (this made the cell layer), and poured 
onto a CATPGlu agar – base layer, in a petri dish. Molten agar was kept warm at 42˚C to 
prevent solidification of CATPGlu agar. The buffer layer was made using 10 ml of 
molten CATPGlu agar poured on top of the cell layer. Unless otherwise specified, the 
drug layer was made using 10 ml of molten CATPGlu agar with an appropriate amount 
of specified drugs (Table 3) poured on top of the buffer layer. Plated cells were incubated 
microaerobically at 37˚C overnight (~20 hours) in a dark chamber.  
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TABLE 1. Bacterial Strains and Plasmids used 
Strains Genotype and/or relevant description Source or reference 
S. pneumoniae   
D39 Type 2 5 
Rx 1 Type 2 unencapsulated 4 
R6 Type 2 unencapsulated 106 
CP1250 malM511 str-1 β-gal- 77 
DP1004 str-1  
SP1446 Str-1 β-gal- mal+ DP1004 x CP1250  
SP1541 pyrB Ω pHT19 derivative of CP1250 
Emr Strr 
This study 
SP1542 ccpA Ω pHT20 derivative of CP1250 
Emr Strr 
This study 
SP1543 truB Ω pHT16 derivative of CP1250 
Emr Strr 
This study 
SP1545 pyrB Ω (pHT9 :: pEVP3) derivative of 
CP1250 Cmr Spcr Strr 
This study 
SP1547 SP1541 carrying pHT9 for pyrB 
complementation Emr Spcr Strr 
This study 
SP1548 SP1542 carrying pHT8 for ccpA 
complementation Emr Spcr Strr 
This study 
SP1549 SP1543 carrying pHT10 for truB 
complementation Emr Spcr Strr 
This study 
SP1551 ccpA Ω (pHT8 :: pEVP3) derivative of 
CP1250 Cmr Spcr Strr 
This study 
SP1552 truB Ω (pHT14 :: pEVP3) derivative of 
CP1250 Amps Cmr Strr 
This study 
SP1559 ccpA Ω pHT20 (EcoRV) derivative of 
DP1004 Emr Spcr Strr 
This study 
SP1564 SP1559 carrying pHT8 for ccpA 
complementation Emr Spcr Strr 
This study 
   
SP1558 pyrB Ω pHT19 (EcoRV) derivative of 
DP1004 Emr Spcr Strr 
This study 
SP1563 SP1558 carrying pHT9 for pyrB 
complementation Emr Spcr Strr 
This study 
SP1552 truB Ω pHT14(BglII)::pEVP3 (BglII) 
derivative of CP1250 Amps Cmr Strr 
This study 
SP1566 truB Ω pHT16 (EcoRI) derivative of 
DP1004 Amps Emr Strr 
This study 
SP1565 SP1566 carrying pHT10 for truB 
complementation Emr Spcr Strr 
This study 
SP1546 Spr1639 Ω  pVJ618 derivative of 
CP1250 Cmr Emr Strr 
This study 
SP1562 Spr1639 Ω  pVJ618 (NcoI) derivative This study 
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of DP1004 Cmr Emr Strr 
SP1572 spxB Ω pZH54 derivative of SP1446 
Cmr Strr This study 
SP1612 SP1562 carrying pVJ619 for spr1639 
complementation Emr Spcr Strr This study 
SP1625 spxB+entire spr0643 Ω (3’spxB+entire 
spr0643::pEVP3) derivative of SP1446 
Cmr strr  This study 
SP1622 spxB+entire spr0643 Ω pHT27 
derivative of SP1446 Emr Strr This study 
SP1623 spxB+entire spr0643 Ω pHT27 
derivative of DP1004 Emr Strr This study 
   
   
E. coli   
XL1 blue MRA 
Stratagene  Stratagene 
DH5α   
C600   
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Plasmid Genotype and/or relevant description Source or reference 
pACYC184 Cmr Tcr 18, 90 
pUC8 derivative of pUC19 Ampr Stratagene 
pUC18 derivative of pUC19 Ampr Stratagene 
pDL278–D Spcr 27 
pDG647 Ampr Emr derivative of pUC19  39 
pEVP3 integrating plasmid in pneumococci 
carrying promoterless lacZ gene Cmr 20 
pVJ609 pACYC184(EcoRV)::1.2 kb PCR 
fragment (using the primers VJ123-F & 
VJ124-R) carrying pneumococcal 
spr1639 that codes for catabolite-
control protein Cmr Tcs  
pVJ611 pSK+(HindIII)::1.6 kb(HindIII) 
fragment containing Emr cassette of 
pDG647  
pVJ617 pVJ609 (SalI) the largest fragment self-
ligated  
pVJ618 pVJ617(EcoRV)::1.6 kb(SmaI) Emr 
cassette of pVJ611 (Inserted within 
spr1639) Cmr Emr  
pVJ619 Spcr, lac- pDL278(SmaI) :: 1.85 kb 
(ClaI) Klenowed fragment of pVJ617, 
carries spr1639  
pVJ577 Emr pRL425(HincII)::klenowed Emr 
cassette from pDG647  
pZH54   
pHT8 pDL278::1.5 kb(SmaI) PCR fragment 
(using the primers, VJ125-F & VJ126-
R) carrying pneumococcal ccpA 
(spr1813) gene that codes for 
catabolite-control protein Spcr  This study 
pHT9 pDL278::1.44 kb(SmaI) PCR fragment 
(using the primers, VJ131-F & VJ132-
R) carrying pneumococcal pyrB 
(spr1155) gene that codes for aspartate 
carbamyl transferase Spcr This study 
pHT10 pDL278::1.1 kb (SmaI) PCR fragment 
(using the primers, VJ129-F & VJ130-
R) carrying pneumococcal truB 
(spr1092) gene that codes for tRNA 
pseudouridine synthase Spcr This study 
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pHT14 pUC8::1.1 kb(SmaI) PCR fragment 
(using the primers, VJ129-F & VJ130-
R) carrying pneumococcal truB 
(spr1092) gene that codes for tRNA 
pseudouridine synthase Ampr  This study 
pHT16 pHT14::1.6 kb fragment carrying the 
Emr determinant from pDG647 within 
the truB gene Ampr Emr This study 
pHT19 pHT9::1.6 kb fragment carrying the 
Emr determinant from pVJ577 
(originally derived from pDG647) 
within the pyrB gene Emr Spcr This study 
pHT20 pHT8::1.6 kb fragment carrying the 
Emr determinant from pVJ577 
(originally derived from pDG647) 
within the ccpA
 
gene Emr Spcr This study 
pHT26 pUC18::0.8 kb (SmaI) PCR fragment 
(using primers VJ171-F & VJ172-R) 
from the mRNA of DP1004 
pneumococcal strain, carrying the 3’ 
end of the spxB and the entire spr0643 
Ampr This study 
pHT27 pHT26(XmnI)::1.6 kb fragment 
carrying the Emr determinant from 
pVJ611 (originally derived from 
pDG647)(XmnI) within the spr0643 
gene Ampr Emr This study 
pHT28 pEVP3::0.8 kb(SmaI) PCR fragment 
(using primers, VJ171-F & VJ172-R) 
from the mRNA of DP1004 
pneumococcal strain, carrying the 3’ 
end of the spxB and the entire spr0643. 
This was derived from SP1625 pop-out 
plasmid Cmr This study 
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TABLE 2. Primers used in this study. 
Primer pairs Sequence Description* 
pEVP3-F 5’-CTTCCACAGTAGTTCACCACCT-3’ 
Forward primer for 
pEVP3 
pEVP3-R 5’-ACCCGGGAGCTCGAATTCTA-3’ 
Reverse primer for 
pEVP3 
VJ115 5’-ATTCGGCGGCTCAATCGGGG -3’ 
Forward primer for 
internal spxB 
VJ116 5’-GATACCAGGAAGGGCAATAC-3’ 
Reverse primer for 
internal spxB 
VJ123 5’-ACTTTTTTGAAGGGGAAG-3’ 
Forward primer for 
spr1639 
VJ124 5’-ATAGAAACTGAATGGAGGC-3’ 
Reverse primer for 
spr1639 
VJ125 5’-CTAAGGTGGTAGCAAGGAGC-3’ 
Forward primer for 
ccpA 
VJ126 5’-CGGACTAACAGGACAGGC-3’ 
Reverse primer for 
ccpA 
VJ127 5'-CGATTTATTTGAAGGACGCAC-3' 
Forward primer for 
trmE 
VJ128 5'-TACCTCTTGTTCCAGCACC-3' 
Reverse primer for 
trmE 
VJ129 5’-ATTGTCCTCCTCCAGAG-3’ 
Forward primer for 
truB 
VJ130 5’-ATTGTTATCTATCACCCG-3’ 
Reverse primer for 
truB 
VJ131 5’-TGGATACTAAACCTTTCCGTG-3’ 
Forward primer for 
pyrB 
VJ132 5’-GTAATGGATTCTTGGTAGCCG-3’ 
Reverse primer for 
pyrB 
VJ159 
 
5’-ATGACTCAAGGGAAAATTACTGCA-3’ 
Forward primer for 
spxB 
VJ160 
5’-TTATTTAATTGCGCGTGATTGCAATCC 
TTCTTCTTC-3’ 
Reverse primer for 
spxB 
VJ171 5’-GGTGTAGACTTCACAAACGCTG-3’ 
Forward primer for 
3’spxB+entire 
spr0643 
VJ172 5’-GACCTATTTCATACGATAAAAATCAAG-3’ 
Reverse primer for 
3’spxB+entire 
spr0643 
*Unless otherwise specified, these primers will amplify the entire genes. 
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TABLE 3. Antibiotic drugs used in this study. 
 Escherichia coli Streptococcus pneumoniae 
Drugs Broth conc. Overlay conc. Broth conc. Overlay conc. 
Ampicilin 75 75 25 25 
Chloramphenicol 15 15 5 15 
Erythromycin 1000 1000 1 1 
Spectinomycin  350 350 150 150 
Streptomycin Not used Not used 200 200 
Tetracycline 10 10 10 10 
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Construction of mutants. 
 
Transformation of E. coli and S. pneumoniae was performed as described 
previously (41, 6). Genomic DNA from Rx1 (4) was extracted and purified as described 
in a previous method (68). DNA fragments containing the open reading frames of spxB, 
spr0643 – 3’spxB, spr1813, spr1639, truB, and pyrB, and trmE were amplified from Rx1 
chromosomal DNA with the respective primers listed in table 2 by using a PCR machine 
(Eppendorf Mastercycler) and the PCR fragments were purified as described by Maniatis 
et al (67). Gel-purifird PCR fragments were ligated to different plasmid vectors for the 
respective purposes as follow: pEVP3 (gene transcriptional studies) (20), pDL278 (gene 
complementational studies) (27), pUC8/pUC18/pUC19 (Stragagene)/pACYC184 (18, 
90)/pSK+ (gene knock-out studies). Restriction sites of every gene and the plasmid 
carriers are listed in table 1. As shown in table 1, an erythromycin cassette (39) was 
inserted within every gene carried by the plasmid vectors. The resulting recombinant 
plasmids were proliferated in E. coli cells (Table 1) and introduced into the strains of Rx1 
as illustrated in table 1. The transformants were selected on CATPGlu agar plates 
containing erythromycin (1 µg/ml). Inserts were confirmed by sequencing carried out at 
the OSU core facility. Knock-out of spr1813, spr1639, pyrB, and truB were confirmed 
phenotypically by a lower survival rate (3-fold) than the wild-type after challenged with 
10 mM H2O2 (Wal-mart). The accession number for each each: spxB NP_358236, 
spr1639 NP_359231, spr1813 NP_359405, pyrB NP_358748, trmE NP_358514, truB 
NP_358685.  
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Experimental assays. 
 
A. β-galactosidase assays 
 
This was performed to quantify an expression of a gene in pneumococcal cells 
with the suggested growth condition mentioned above. Unless specified otherwise, the 
cells were harvested at OD550 = 0.3. To carry out this assay, 1 ml of cells in a 13 mm 
slip cap tube was kept on ice for 10 min to slow down cell growth. The cells were 
mixed with 50 µl of lysis solution [10% (v/v) triton-X-100 with 0.04% DOC (w/v) in 
distilled water], vortexed, and lysis was performed at 37˚C for 5 min or until the 
solution became clear. To start the β-galactosidase reaction, 0.5 ml lysate was 
transferred into a 1.5 ml disposable cuvette containing 0.5 ml of Z buffer (1.61 g of 
Na2HPO47H2O, 0.55 g of NaH2PO4H2O, 0.075 g of KCl, 0.025 g of MgSO47H2O in 
100 ml distilled water, autoclaved, 0.27 ml of β-mercaptoethanol added before use), 
and 0.2 ml of ONPG (10 mg/ml). The reaction was carried out in the dark at room 
temperature for 90 min or until yellow color was developed. To stop the reaction, 0.5 
ml of Na2CO3 (1 M) was added to the reaction mixture, mixed using the same pipette 
tip by pipetting up and down 3 times. Then, the optical density at 420 nm was measured 
in a spectrophotometer (Spectronic 1001, Milton Roy CO.). Miller units were 
calculated by using the formula: Miller unit = 1000 * OD420 /time of reaction (minute) 
/OD550 (cell density) (67). 
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B. H2O2 sensitivity assays 
 
Bacterial cells, pregrown to OD550 = 0.1 were diluted by 103-fold before distributing 
1 ml aliquots of the diluted sample into four test tubes, and three of the diluted samples 
(one diluted sample was the control for no H2O2 treatment) treated with 10 mM H2O2 
(3% original, from Wal-mart ) were incubated with the control at 37ºC for 30 min. H2O2 
challenged samples were then mixed with 4 ml of CATPGlu broth containing 4% of 
sheep blood (provided by the college of Veterinary Medicine at OSU) to remove 
exogenous H2O2 and all tubes were kept on ice until plating. Cell density with or without 
H2O2 treatment was assessed on agar plates by the overlay method. The survival rate in 
percent was assessed by dividing the CFU of 1 ml cultures after exposure to H2O2 by the 
CFU of the control tube without H2O2.  
       
C. H2O2 production assays 
 
This was performed to measure the amount of H2O2 being released by the cells. No 
cell lysis was carried out. A stardard plot was established to correlate amount of H2O2 
(mM) to OD560 absorption value (Fig. 2). 1 ml of each culture was spun down at 15,000 x 
g in 1.5 ml centrifuge tubes for 5 min at room temperature (~25˚C). 200 µl aliquots of 
each supernatant was mixed with 700 µl of CATP, and 100 µl of a solution containing 
1.5 mg of ABTS [2,2’azinobis(3-ethylbenzthiazolinesulfonic acid)]/ml and 0.1 mg of 
horseradish peroxidase/ml in 0.1 M potassium phosphate buffer (pH 7.0). Blank solution 
was prepared using 700 µl CATP, 200 µl spin-down CATPGlu, and 100 µl substrate. The 
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reaction was allowed to take place at room temperature under dark condition for 15 min. 
Optical density at OD560 was measured and result was recorded. The formula, y = 
0.4159x – 0.1118 for calculating H2O2 concentration in mM was deduced from the 
standard curve demonstrated in figure 2. 
 
y = 0.4159x - 0.1118
R2 = 0.9991
0
0.2
0.4
0.6
0.8
1
1.2
0 0.5 1 1.5 2 2.5 3 3.5
[H2O2], mM
Optical density at 
560nm
 
Figure 2. Standard plot for the measurement of H2O2 concentration (mM). Reaction was done with 0.1 ml 
of H2O2. 
 
Search for the presence of an extra-cellular peptide inducing H2O2 production. 
 
5 ml aliquots of bacterial cells at OD550 = 0.3 grown in 125 ml flask were 
distributed into seven sterile 125 ml flasks containing 1/100 volume of supernatant 
harvested from pregrown cells at different growth phases, and all the samples including a 
control (added sterile distilled water, no supernatant added) were incubated under ceiling 
lights for 90 min. H2O2 production assay was then performed for each tube. 
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Another experiment was performed using proteinase K (20 mg/ml) mixed with 5 ml 
aliquots of bacterial cells pregrown to OD550 = 0.23 in three of 125 ml flasks, and another 
three of the same flask containing the same culture treated with sterile distilled water 
were used as controls, followed by incubation of each sample at 37˚C under ceiling lights 
with aeration. Optical density at OD550 of each sample was measured. H2O2 production 
assay was then performed for each tube. 
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CHAPTER IV 
 
 
FINDINGS 
 
Part I. Resistance to exogenous H2O2 in S. pneumoniae. 
 
 
 
(a) Identification of genes which are up-regulated during growth in lactose. 
 
The growth of pneumococcal cells in lactose led to significantly increased 
survival when exposed to exogenous H2O2. We sought to identify the genes that are not 
involved in the metabolism of lactose but which confer the observed resistance to 
oxidative stress. To accomplish this goal, the pneumococcal chromosome was randomly 
mutagenized by the insertion-duplication. The insertion-duplication mutagenesis involves 
insertion of a heterologous reporter gene within the chromosome via transformation. This 
is done first by ligating a fragment of chromosomal DNA to the heterologous DNA in 
vitro. The ligated circular DNA is introduced into the cells by transformation. The DNA 
taken up circularizes inside the cell and the chromosomal fragment of the DNA directs 
the insertion of the heterologous reporter DNA at the site of homology. During this 
process, the directing DNA fragment is directly duplicated flanking the heterologous 
DNA by a mechanism that is still unclear (Fig.3) (63). The reporter gene we employed
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in this study was the heterologous E. coli plasmid vector, pEVP3 (20). This plasmid 
carries E. coli origin of replication and is incapable of independent of replication in 
pneumococcal cells. It carries a chloramphenicol resistance gene that expresses both in E. 
coli and pneumococcus. We only found three mutants that were blue on CATPLac and 
X-gal but remained white on CATPGlu and X-gal plates. The level of expression of 
genes from these three mutants was measured by β-galactosidase assay (Fig. 5, 6). 
 
Figure 3. Mechanism of insertion-duplication in S. pneumoniae. Contrasting ways of recombination which 
depend upon the topology of the donor DNA in transformation of pneumococcus. Panel A shows the 
integration of a genetic marker by double recombination involving the flanking DNA.  Heterologous 
marker in a circular DNA can be inserted with the help of the directing DNA that gets duplicated as direct 
repeats as shown in panel B. 
 
 
Next, I sought to identify the place of insertion of the reporter plasmid in each of 
these clones. For this purpose, I grew each of the clones without any selective pressure 
for several generations overnight at 37oC. Due to the presence of the generation of direct 
repeats in the insertion-duplication mutagenesis employed in the construction of these 
mutants, it was expected that the direct repeats would recombine with each other leading 
to the excision of the inserted DNA. Such a spontaneous “curing” has been reported to 
occur in such mutants at a low but detectable frequency (20, 63). The excised circular 
molecule would be unable to replicate and be expected to be eventually lost. Following 
overnight growth, chromosomal DNA was isolated from these cultures. The purified 
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chromosomal DNA was used in transformation of E. coli cells. Due to the presence of E. 
coli origin of replication, the “cured” plasmid molecules were able to yield transformants. 
The sequence of passenger DNAs in the E. coli recombinant plasmids isolated from each 
of these clones was subsequently obtained using the primers, pEVP3-F and pEVP3-R. 
The DNA sequence determination showed that the three genes which were up-regulated 
by growth in lactose were bgaA (spr0565), in pHT4, pyrB (spr1155), in pHT6, trmE 
(spr0920), in pHT7, and truB (spr1092), in pHT5. Orfs of pyrB and truB were amplified 
as described in Methods and Materials. We did not pursue our study with the bgaA gene 
because it has been well studied and the encoded function β-galactosidase has been 
confirmed (56, 117). Later, we were interested in the role of pneumococcal catabolite 
control proteins (CCP), spr1639 and spr1813. Both spr1813 and spr1639 have been listed 
in the family of lactose repressive protein, LacI (NCBI). However, only spr1813 (CcpA) 
has been experimentally shown to possess the regulatory function (38, 50, 56). An 
implication that the spr1813 regulates the transcription of pyrB has been reported recently 
(44). It is also shown to regulate the bgaA operon by binding to the catabolite-responsive 
element (cre) site located adjacent to the promoter (56) (Fig. 4). There is no cre site on 
the operons of trmE and truB that have been determined by comparing the cre sequence 
to the sites around the promoters. However, no report on spr1639 function is available to 
date. So, we also amplified the orf of these two ccp genes. In summary, mutations were 
introduced in the genes spr1639, spr1813, pyrB, and truB. Introduction of mutation into 
trmE gene was not successful due to cloning of the gene in E. coli did not produce any 
true clone.  
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Figure 4. Promoter region of the pts-bgaA operon. The cre consensus sequence is aligned below the 
promoter sequence (54). 
 
 
(b) Identification of mutants susceptible to H2O2 
   
We then determined whether lactose-induced genes were responsible for H2O2 
resistance. Lactose pregrown cultures were exposed to H2O2, and survival was assessed 
by colony counts. Strains SP1541, SP1543, SP1558, SP1559, SP1562, SP1566, carrying 
an erythromycin cassette inserted within the genes pyrB, truB, spr1813 or spr1639, were 
found to have lost resistance to H2O2 by at least 3-fold lower than the wild-type, as 
determined by fold difference of the survival rates (survival in lactose divided by survival 
in glucose) even when pregrown in lactose (Table 4, 5). Mutation of pyrB gene both in 
CP1250 and DP1004 backgrounds was found to have no significant differences in the 
survival rates when compared with the wild-type.  
 
(c) Complementation studies  
 
We next determined whether loss of the genes contributed to the increased H2O2 
sensitivity. Strains SP1547, SP1549, SP1563, SP1565, complementing to mutagenized 
genes were constructed by introducing a recombinant plasmid of pDL278 carrying a 
respective gene, under control of the plasmid promoter, into the mutants.  
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Complementation of truB- and spr1813-deficient mutants in DP1004 background 
restored H2O2 resistance. In fact, H2O2 resistance was significantly higher in pyrB-
complemented mutant (SP1558) than its parent strain. The insertion-mutagenesis that 
inactivates pyrB in the SP1541 and SP1558 strains is likely to have a polar effect, since 
pyrB operon has been shown to carry downstream genes of carA and carB in a close 
bacterial species Lactobacillus plantarum (72). Arrangement of genes by NCBI also 
supports this finding (Fig. 26). The resulting carA and carB are unable to produce 
peroxynitrite, a highly cytotoxic compound, resulting higher survival to H2O2 (Fig. 26, 
27) (44, 71). However, failure of SP1541 to restore resistance to H2O2 could be due to a 
mutation in β-galactosidase gene in CP1250 which contributed to the polar effect of the 
mutant. On the other hand, significant low resistance of spr1639-complemented mutant to 
H2O2 might have caused by the gene that being highly expressed from the plasmid.  
 
In summary, I have (a) identified 5-genes in pneumococcus, truB, trmE, pyrB, 
ccpA, spr1639, that are upregulated during growth in lactose as compared to in glucose, 
(b) shown that these are not involved in the metabolism of lactose, and (c) that at least 3-
genes, truB, pyrB, and ccpA, which are involved in conferring 3-fold increased 
survivability to H2O2 when grown in lactose. The loss of the gene activities resulted in 
the decreased survival whereas complementation restored the effect. The specific 
mechanism employed by the genes that regulates the resistance to H2O2 is unknown. 
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TABLE 4. Percent survival rate of the mutants and the complemented strains created 
following H2O2(b) treatment, in CP1250 background (104 CFU) 
 
  Grown in  
Strains Genotype Glucose(a) Lactose(a) Fold difference 
SP1543* truB- 1.7±1.6 2.5±1.9 1.5 
SP1549§  truB 
complement 3.0±2.4 4.0±2.9 1.3 
SP1541* pyrB- 0.6±0.3 2.5±1.6 4.2 
SP1547§ pyrB complement 1.9±2.3 4.8±3.7 2.5 
CP1250 Wild-type 2.3±1.1 13.4±7.0 5.7 
(a) Concentration of glucose used = 11 mM, concentration of lactose = 11 mM. 
(b) Concentration of H2O2 used for treatment = 10 mM. Time of H2O2 exposure = 30 min. 
Mean values of triplicates from six independent experiments (±SE) are presented. * Negative 
mutant P values: SP1543: P < 0.05, SP1541: P > 0.05. § Complement P values: SP1549: P > 
0.05, SP1547: P > 0.05. 
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Table 5. Percent survival rate of the mutants and the complemented strains created following 
H2O2(b)  treatment, in DP1004 background (104 CFU) 
 
 
 
Grown in  
Strains Genotype Glucose(a) Lactose(a) Fold difference 
SP1566Ө truB- 5.0±4.0 3.1±1.7 ~1.0 
SP1565∆ truB complement 2.2±1.0 6.4±2.7 ~2.9 
SP1558 Ө pyrB- 3.7±1.7 6.7±1.9 ~1.8 
SP1563∆ pyrB complement 6.3±1.9 67.0±12.0 ~6.7 
SP1559 Ө spr1813- 48.0±13.0 27.0±7.0 ~1.0 
SP1564∆ spr1813 complement 3.3±0.5 10.0±0 ~3.0 
SP1562 Ө spr1639- 1.8±0.8 1.0±0 ~1.0 
SP1612∆ spr1639 complement 1.4±0.4 1.6±0.26 ~1.0 
DP1004 Wild-type 4.2±0.3 13.0±2.6 3.0 
 
(a) Concentration of glucose used = 11 mM, concentration of lactose = 11 mM. 
(b) Concentration of H2O2 used for treatment = 10 mM. Time of H2O2 exposure = 30 min. 
Mean values of triplicates from six independent experiments (±SE) are presented. Ө Mutant P 
values: SP1559/SP1562/SP1566: P < 0.05, SP1558: P > 0.05. ∆ Complement P values: 
SP1565: P > 0.05, SP1563: P < 0.005, SP1564: P > 0.05, SP1612: P < 0.05. 
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(d) Gene expression studies. 
 
In order to quantify expression of the genes, we carried out β-galactosidase assays 
for strains SP1545 (pyrB), SP1546 (spr1639), SP1551 (spr1813), SP1552 (truB), 
constructed by inserting a lacZ gene adjacent to the promoters of the genes, in the 
presence of glucose or lactose. Unexpectedly, different levels of expression were 
observed only in truB and spr1639, and both demonstrated approximately 4-fold higher 
expression in lactose than glucose (Fig. 5, 6) (Table 6).    
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Figure 5. Transcriptional levels of the genes pyrB in SP1545, and truB in SP1552. These strains were 
constructed by insertion-duplication within each of the gene and promoterless lacZ was located 
downstream of the promoter of each gene. The cells were grown microaerobically in glucose and lactose, 
separately at 37ºC. Cells at turbidity OD550 = 0.3 were harvested for β-galactosidase measurement, using 
Miller unit. Each mutant was derived from CP1250. CP1250 carries knock-out genes in beta-galactosidase 
and also maltose metabolism. Unless specified or otherwise, β-galactosidase expression levels in CP1250 
were observed at ~ 0.3 in glucose and 0 in lactose miller units. Representative results of the average of one 
independent experiment in triplicate are shown. N = 3. 
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Figure 6. Transcriptional levels of the genes spr1639 in SP1546 and spr1813 in SP1551. This strain was 
constructed by insertion-duplication within the gene and promoterless lacZ was located downstream of the 
promoter. The cells were grown microaerobically in glucose and lactose, separately at 37ºC. At OD550 = 
0.3, the cells were harvested for beta-galactosidase measurement, using Miller unit. SP1546, mal+, lac-, was 
derived from CP1250 homologously recombined with DP1004 DNA. Representative results of the average 
of at least 1 independent experiment in triplicate are shown. N = 3. 
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(e) Cultural characteristics of the mutants. 
 
We then determined whether the mutants have any defect in the general 
phenotypic properties by conventional tests and measurement of the growth rates. Results 
of the conventional tests were tabulated in Table 6. Physiologically, the growth rates 
were found to behave similar to wild-type, but pyrB-deficient mutant, pyrB-
complemented mutant, and spr1813-complemented mutant, which failed to have the cell 
density exhibited by the wild-type (Fig. 7). Two independent growth curves were 
performed, and both showed the same doubling times for each pair of mutant. 
 
Mutation of pyrB inactivates a mechanism required for arginine and pyrimidine 
biosynthesis; therefore, it contributed to a defect in the growth rate of SP1558 and 
SP1563. Low cell density of SP1564 might have been caused by the gene being highly 
expressed from the plasmid, and abundance of it might repress growth-related genes. 
Overall, the data suggested that there was no significant defect in general phenotypic 
characteristics, but some growth rates were affected. 
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Figure 7. Growth curves of cells carrying a mutation in the lactose-regulated genes. These genes have 
been tested for exogenous H2O2 resistance both in glucose and lactose. Mutagenized form of these 
genes decreases its resistance to exogenous H2O2. This result was established by growing these strains 
microaerobically in CATPGlu in 13 mm slip cap test tubes at 37ºC. Cell growth was monitored by 
measuring turbidity at OD550. Representative results of one independent experiment are shown.  
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Table 6: Overall cultural characteristics of spr1639, spr1813, pyrB and truB mutants. 
 
Strains/gene Cell Morph. Hemolytic pattern Bile solubility Autolysis Β-gal assay, Miller unit 
H2O2 
Sensitivity 
Lac/glu (ratio) 
SP1551 Gram “+”, diplococci α-hemolytic Yes  Yes 
Glu (58.5) 
Lac (57.0) - 
SP1559/spr1813- Gram”+”, diplococci α-hemolytic Yes Yes - ~1.0 
SP1564/spr1813 
complement Gram “+”, diplococci 
α-hemolytic Yes Yes - ~3.0 
       
SP1545 Gram “+”, diplococci α-hemolytic Yes  Yes 
Glu (8.30) 
Lac (6.00) - 
SP1558/pyrB- Gram “+”, diplococci α-hemolytic Yes Yes - ~1.0 
SP1563/pyrB 
complement Gram “+”, diplococci 
α-hemolytic Yes Yes - ~6.7 
       
SP1552 Gram “+”, diplococci α-hemolytic Yes  Yes 
Glu (1.89) 
Lac (5.96) - 
SP1566/truB- Gram “+”, diplococci α-hemolytic Yes Yes - ~1.0 
SP1565/truB 
complement Gram “+”, diplococci 
α-hemolytic Yes Yes - ~3.0 
       
SP1546 Gram “+” diplococci α-hemolytic Yes Yes Glu (2.30)  
SP1562/spr1639-  Gram “+” diplococci α-hemolytic Yes Yes Lac (10.4) ~1.0 
SP1612/spr1639 
complement 
Gram “+” diplococci α-hemolytic Yes Yes - ~1.0 
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Part II: H2O2 resistance is mediated by SpxB activity 
(a) H2O2 resistance is correlated with H2O2 production.  
 
In a previous study, the concentration of H2O2, determined from the supernatant 
of cultures grown microaerobically in glucose, was found to be maximal during 
stationary phase (7). This finding suggested that levels of resistance might also vary 
throughout the growth phases (81). The H2O2 production was determined simultaneously 
with H2O2 sensitivity test from cultures grown microaerobically to early log-phase, mid-
log phase, stationary phase and death phase. As expected, the culture producing increased 
concentration of H2O2 also showed more resistance to H2O2 (Fig. 8A). In addition, the 
culture with no elevated H2O2 production was also found to have an increased H2O2 
resistance as the growth phase entering stationary phase (Fig. 8B). Similar result was 
observed in another experiment (data not shown). Together, the data suggested that there 
was an association between H2O2 resistance and the growth phase.  
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Figure 8. Effect of exogenous H2O2 on the survival rate of DP1004, grown to different phases of growth.  
Cells were grown microaerobically in CATPGlu at 37ºC. Cells from various growth phases were treated 
with 10 mM exogenous H2O2. Simultaneously, endogenous H2O2 production of the cells and its cell density 
were measured before the exogenous H2O2 treatment. Bars represent number of survivors per 1000 cells 
while the line represents cell density measured at the various points. X-axis represents accumulated H2O2 
concentration, mM harvested at various growth points, the left Y-axis represents survival rate, and the right 
Y-axis represents cell density OD550. DP1004 was used for this study. It is derived from Rx1 pneumococcal 
strain. (A) Pneumococcal cells grown in a 250 ml flask. (B) Pneumococcal cells grown in a 13 mm 
diameter of 5 ml tube. Mean values of duplicates from one independent experiment (±SE) are presented. N 
= 2.  
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 (b) Monitoring spxB expression during growth. 
 
We next tested the hypothesis that spxB expression would also be maximal during 
stationary phase. The transcriptional levels of the gene spxB-null mutation in SP1572, 
constructed by inserting a lacZ gene adjacent to the promoter of spxB, at various growth 
points were measured. Unexpectedly, the transcriptional level of spxB during stationary 
phase was minimal, while its maximum transcription was found at early- as well as mid-
log phases (Fig. 8, 11). Similar expression profile was observed in another two 
experiments (data not shown). 
  
 In order to determine whether the incorrelation of spxB expression with the H2O2 
production was due to an artifact, we measured both simultaneously. Strain 1625 was 
constructed as demonstrated in figure 10 because previous construction of SP1604 
(contains only the spxB orf) exhibited no H2O2 production (data not shown). This newly 
made strain allowed us to measure both spxB expression and the H2O2 production, so a 
clean correlation could be established. In SP1604, two copies of entire spxB orfs are 
expected due to the insertion-duplication by pEVP3 recombinant plasmid which causes 
genome shifting and the loss of ability to produce H2O2 (Fig. 9).  
  
 Figure 9. Suggested arrangement of spxB and the genes surrouding it, NCBI (69). 
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Figure 10. Illustration of recombination products from circular chimeric DNA donors targeting the spxB 
operon. (A) Suggested arrangement of spxB and the glyoxalase (spr0643) gene, obtained from NCBI. 
Primers sequences are available in table 2. (B) A recombination product resulting from the duplication of 
entire spxB gene carried in pEVP3 plasmid, pZH54, generated by ligating PCR product to the plasmid. (C) 
A recombination product resulting from the duplication of 3’ end spxB which is represented by (+) through 
the whole orf of glyoxalase. (B) and (C): the horizontal-striped boxes represent the region of spxB gene, the 
vertical-striped boxes represent the region of glyoxalase, and the white box represent the promoter of the 
operon. 
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 Both levels of spxB expression, measured by β-galactosidase assay, and H2O2 
production were measured from unwashed and washed samples. Samples were washed to 
avoid any artifact that might be caused by accumulation of H2O2 during growth. In both 
cases, the observations were consistent with previous findings demonstrating that there 
was no parallel relationship between expression of spxB and the activity of the enzyme 
(Fig. 8, 11, 12). A similar result was also observed in another experiment (data not 
shown).   
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Figure 11. Transcriptional level of spxB during the growth cycle. To study this, a strain was constructed by 
insertion duplication within the gene and promoterless lacZ was located downstream of its promoter; 
namely, SP1572. The cells were grown microaerobically in glucose at 37 ºC in a 125 ml flask. Every 40 
minutes of incubation, the cells were harvested for β-galactosidase measurement, using the Miller unit. 
SP1572 was derived from SP1446. Mean values of duplicates from one independent experiment (±SE) are 
presented. N = 2.  
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A.  
 
B.  
 
Figure 12. Study of SpxB activity in line with its expression from sample, SP1625: before 
washed/unwashed (A), and washed (B). Cells were grown microaerobically at 37˚C in CATPGlu in a 250 
ml flask. OD550 was monitored and 6 ml cells were harvested at OD550 = 0.02 with 1 ml used for β-
galactosidase assay of spxB expression and the endogenous H2O2 measurement, and the rest was washed in 
fresh CATP broth before resuspended in 5 ml fresh CATPGlu containing Cmr for selection. 1 ml of 
resuspended cells was used for H2O2 measurement (background, no significant detection; data not included 
here) and the rest was incubated for 1 hour at the same condition used before. The result is demonstrated in 
figure (B). Mean values of duplicates from one independent experiment (±SE) are presented. N = 2. 
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(c) Function of spr0643 in H2O2 production. 
 
In a previous report, spxB was found to come from a monocistronic operon (86). 
We therefore tested the hypothesis that spr0643 is not part of spxB operon. cDNA was 
prepared by using primers that are able to provide the transcript of 3’ spxB – entire 
spr0643 (total size of ~800 bases) if spxB and spr0643 were co-transcripted. The 
expected size of cDNA was present in a gel picture (Fig. 13). Sequence result of the 
cDNA suggested that the spr0643 was copresent with spxB on the same transcript, and 
spxB operon was not monocistronic.  
 
Then, we determined whether unexpressed spr0643 was responsible for the loss of 
ability to produce H2O2. The spr0643 knock-out mutants were also constructed in lac-
deficient background of S. pneumoniae strain to avoid any artifact from the removal of β-
galactosidase activity. The H2O2 concentratons present in overnight cultures SP1622 and 
SP1623 were found to be similar as in the wild-type strains (Fig. 14). This suggested that 
there was no direct involvement of spr0643 in the H2O2 production, and the SP1604 may 
not be a true clone.  
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Figure 13. Agarose gel electrophoresis of cDNA resulting from the product of RT-PCR of DP1004 using 
primers VJ171-F and VJ172-R. (a) cDNA produced from DNA with primers VJ171-F and VJ172-R. (b) 
DNA Negative control by treating RNA sample with RNase. (c) Size markers are given by 1 kb ladder. 
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Figure 14. Measurement of H2O2 produced by glyoxalase-deficient mutants. Ability of glyoxalase-deficient 
mutants to produce H2O2 was studied by measuring H2O2 amount from overnight culture grown 
microaerobically at 37˚C under ambient light. Mutants are SP1622 (glyoxalase mutant in SP1446 
background), and SP1623 (glyoxalase mutant in DP1004 background). The SP1446 is genotypically the 
same as in the DP1004 and CP1250 except, it is β-galactosidase negative and maltose metabolism normal, 
respectively. Cells were grown both in flasks and tubes. The supernatant was harvested from sample after 
about 20 hours incubation for H2O2 measurement. Mean values of duplicates from one independent 
experiment (±SE) are presented. N = 2. 
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(d) Monitoring H2O2 production for the non-catabolic mutants. 
 
Previously, mutants carrying a mutation in the genes spr1639, spr1813, pyrB or 
truB were highly sensitive to H2O2 (Table 4, 5). We therefore tested the hypothesis that 
strains that were sensitive to H2O2 would also be unable to produce H2O2. The H2O2 
concentrations from overnight cultures were determined. Lacose was also used because it 
seemed to induce H2O2 resistance through these genes (Table 4, 5). Cultures grown in 
glucose showed reduced H2O2 concentrantration in mutants SP1558 (pyrB-deficient, 2-
fold lesser), SP1559 (spr1813-deficient, 5-fold lesser), and SP1566 (truB-deficient, 5-fold 
lesser) while no apparent defect was found in the mutant SP1562 (spr1639-deficient) 
even when grown in the presence of lactose (Fig. 15).  
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Figure 15. Measurement of H2O2 produced by spr1639, spr1813, pyrB, truB mutant strains. These negative 
mutants carry a gene that is responsible for catabolite-regulated H2O2 resistance. They are SP1558 (pyrB-), 
SP1559 (spr1813-), SP1566 (truB-), and SP1562 (spr1639-). These insertion mutants are derived from 
DP1004 background, the wild-type of this test. Cells were grown microaerobically in glucose and lactose, 
separately at 37˚C, in a separate 125 ml flask, under ambient light. Supernatant was harvested from 
overnight samples after 20 hours incubation for H2O2 measurement. Mean values of duplicates from one 
independent experiment (± SE) are presented. N = 2.    
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(e) Monitoring H2O2 production during growth in different carbohydrates. 
       
In a previous study, H2O2 resistance of pneumococcal cells was found to be 
highly reduced when grown in several sugars, but in lactose (Table 1). We therefore 
determined whether loss of the resistance was due to a reduction in the H2O2 production. 
The H2O2 concentrations from overnight cultures were determined. Normal H2O2 
concentrations (3 – 5 mM) were found in all supernatants of cultures grown in all types of 
sugar except, in fructose or galactose which most likely due to the cultures did not grow 
well in those sugars (Fig. 16).  
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Figure 16. Measurement of H2O2 produced by DP1004 grown in various carbohydrates. DP1004 cells were 
grown microaerobically at 37˚C in various sugars, separately in a 125 ml flasks and a 13 mm slip cap test 
tube. Both the tubes and the flasks were incubated overnight under ambient light. Supernatants were 
harvested from sample after about 20 hours incubation for H2O2 measurement. The DP1004 is the wild-
type strain. Mean values of duplicates from one independent experiment (±SE) are presented. N = 2. 
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In order to determine whether highly reduced H2O2 concentrations in cells grown 
in fructose or galactose were due to inability to produce H2O2, we monitored growth rates 
in those sugars. Cultures were also grown in other sugars for comparison purpose. 
Turbidities were monitored at various growth points until death phases were reached. 
Growth curves were plotted for demonstration purpose. A similar doubling time at 40 
minutes was found among cultures grown in all tested sugars, but galactose (~80 
minutes) (Fig. 17). Cell density was found to be 2-fold less with the culture grown in 
fructose compared with others. This suggested that there was an association between 
growth ability and the spxB activity.  
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Figure 17. Growth curves comparison from pneumococcal cells grown in various carbohydrates. DP1004 
cells were grown microaerobically at 37˚C in different carbohydrates in 13 mm slip cap test tubes, under 
ambient light. Cell density was monitored by measuring turbidity at OD550 throughout the life cycle. The 
DP1004 is the wild-type strain. Representative results of one independent experiment are shown. 
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We then checked whether higher H2O2 resistance in cultures pregrown in lactose 
to OD550~0.1 was due to induced H2O2 production. The H2O2 concentration present in 
supernatants of cultures was determined. As expected, at turbidity 0.1, about 2-fold 
higher H2O2 concentration was found in the supernatant containing lactose than the 
glucose (Fig. 18, 19A). In fact, the H2O2 production was found to gradually increase 
when grown in lactose while gradual increment in glucose was observed only during 
stationary phase. Together, the data suggested that lactose-mediated H2O2 resistance 
requires the presence of SpxB, but H2O2 production could be eliminated. 
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Figure 18. Production and accumulation of H2O2 during the growth cycle. Cells were grown 
microaerobically in lactose, at 37˚C, under ambient light. OD550 was measured throughout the life cycle and 
H2O2 measurement was done every 40 minutes of growth, started from OD550 = 0.07. The DP1004 is the 
wild-type strain. Mean values of duplicates from one independent experiment (±SE) are presented. N = 2. 
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  In a previous report, glucose was found to repress H2O2 production in S. 
pneumoniae (104). We therefore tested the hypothesis that transferring H2O2 producing 
cells to fresh medium would repress H2O2 production. The H2O2 concentration present in 
supernatants of unwashed or washed cultures was determined. Cell density from washed 
samples was assessed by colony counts. In contrast, H2O2 production was found to 
continue in washed cultures originated from stationary phase which contained highest 
H2O2 concentration as well as cell density (Fig. 19). A similar observation was found in 
previous study using SP1625 to correlate spxB expression with the activity of washed 
cultures (Fig. 12B).  
 
In order to determine whether high cell density was responsible for induced H2O2 
production, we measured H2O2 concentration present in supernatants of diluted cultures 
originally pregrown to stationary phase. H2O2 production was found to continue in all 
diluted samples (Fig. 20). Together, the data suggested that H2O2 production could be 
induced by high cell density and was inreversible after commitment. 
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Figure 19. Regulation of the ability of DP1004 to produce H2O2 by the growth phase and cell densitiy. 
(A) Growth phase changes the ability of DP1004, grown in CATPGlu to produce H2O2. Cells were grown 
microaerobically in CATPGlu in a 250 ml flask, at 37˚C, under ambient light. Cell density was monitored 
throughout the cell life cycle, started from OD550 = 0.03. Supernatant was harvested at every 1 hour of 
incubation for accumulated H2O2 measurement. This is the result of unwashed sample. Cell density was 
monitored by measuring turbidity at OD550, as demonstrated on x-axis. Subsequently, H2O2 was measured 
and demonstrated on Y-axis (gray bars). Result from washed sample is in (B). (B) Cell density changes the 
ability of DP1004 to produce H2O2. After cells were washed at every one hour incubation, cells were 
resuspended in fresh CATPGlu and grown microaerobically in a 125 ml flask, at 37˚C, under ambient light 
for one hour. Cell density was monitored by measuring turbidity at OD550 (Line with dots, right-Y-axis) and 
50 µl cells was stored at -80˚C in 10% glycerol for viable plating later (white bars, X-axis). 1/20 dilution 
was introduced to the sample during storage. 1 ml of the culture was used to carry out H2O2 measurement 
assay (white bars, left-Y-axis). Mean values of duplicates from one independent experiment (±SE) are 
presented. N = 2. 
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Figure 20. Continual production of H2O2 from DP1004  pregrown to stationary phase. Cells were grown 
microaerobically in CATPGlu in a 125 ml flask, at 37˚C, under ambient light. At OD550 = 0.64, the cells 
were harvested. Concentration of H2O2 produced by cells was measured ([H2O2] = 2.69 mM) before 
washing and diluting the cells to various cell densities. The diluted cells were grown separately in a 125 ml 
flask at 37˚C for 1 hour. Supernatant was harvested from each dilution for H2O2 measurement. Bars 
represent the endogenous H2O2 production after dilution with Y-axis the concentration of H2O2 produced, 
while the X-axis represents the dilution factors and the optical density of turbidity after dilution, and after 1 
hour incubation. 
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(f) Determination of the presence of quorum-sensing peptide in the activation of 
H2O2 production.  
 
Induction of pneumococcal competence by competence stimulating peptide (CSP) 
was found to take place between cell density of 0.05 – 0.15 read at an optical density of 
600 nm (7). We therefore checked this property in H2O2 production by measuring H2O2 
concentration present in supernatants of cultures treated with supernatants collected from 
different growth points at one hour interval from cell density of 0.1 read at an optical 
density of 550 nm (previous data showed no apparent differences from 600 nm) to 
stationary phase. A cell density of 0.3 was used for the study because the cells are 
restored to exponential growth from lag-phase and H2O2 production is not activated 
during this point after inoculation (refer to method and material). No significant effect on 
H2O2 production was observed (Fig. 21A).  
 
We then employed another way to test the possibility of the presence of a 
quorum-sensing peptide. The H2O2 concentration present in supernatants of cultures 
pretreated with or without proteinase K during aerated growth was determined. 
Unexpectedly, in both cases, the cells exhibited normal H2O2 concentrations regardless of 
the presence of proteinase K (Fig. 21B). Together, the data confirmed that the connection 
between quorum-sensing peptide and the H2O2 production did not exist.  
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Figure 21. Determination of extra-cellular peptide that induces the ability of DP1004 to produce H2O2. 
(A) Effect of the supernatant, harvested from various growth phases on the ability of DP1004 to produce 
H2O2. Cells were pregrown microaerobically in CATPGlu in a 250 ml flask at 37˚C under ambient light. At 
OD550 = 0.3, 5 ml of cells were aliquot into 125 ml flasks and treated with the supernatant collected 
previously at various growth phases. Supernatant was harvested after 90 minutes incubation for H2O2 
measurement. Bars represent H2O2 concentration with Y-axis indicates the concentration values while broth 
# 1 – 6 collected from sample between early growth phase (1) and late growth phase (6) is represented on 
X-axis.  (B) Measurement of H2O2 produced by DP1004 treated with proteinase K (K+) or without 
proteinase K (K-) treatment. Cells pregrown to OD550 = 0.32 were aliquot into two 125 ml flasks. 
Proteinase K was added to one of the flask. The two flasks were incubated aerobically for 1 hour. Turbidity 
was measured. Supernatant was used to measure the amount of H2O2 produced by the cells. Left-bar 
represents result from proteinase K treated sample while the right-bar represents result from non-proteinase 
K treated sample. Bars represent H2O2 concentration measured from the samples’ supernatant with Y-axis 
indicating H2O2 concentration while the type of treatment is represented on the X-axis. Mean values of 
duplicates from one independent experiment (±SE) are presented. N = 2. 
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SpxB has been shown to require O2 for its activity (81). This finding suggested 
that production of H2O2 by the cells might vary when growing in different apparatuses.  
The H2O2 concentration present in supernatants of cultures grown in a test tube or flask 
was determined. As expected, the H2O2 concentrations were found to differ between the 
two apparatuses by 8-fold higher concentration more in the flask than in the counterpart 
(Fig. 22). This suggested that the O2 content in different apparatuses varied and test tube 
of 13 mm diameter did not allow H2O2 production.  
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Figure 22. Effect of vigorous shaking on the ability of DP1004 to produce H2O2. DP1004 cells were grown 
microaerobically in CATPGlu at 37˚C, in a 125 ml flask and a 13 mm slip cap test tube. At OD550 ~ 0.2, 
vigorous shaking at 200 r.p.m was supplemented for both tube and flask samples for 1 hour in ambient 
lighting. Supernatant of each sample was harvested for H2O2 measurement. Mean values of duplicates from 
one independent experiment (±SE) are presented. N = 2. 
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In a protein cystalization study, SpxB is shown to contain flavin adenine 
dinucleotide (FAD) (86). It is well-known that light-activated proteins, such as LOV 
proteins (light-O2-voltage), are composed of a flavin compound (102). Recently, an 
association between light and gene regulation has shown to cause virulence in Brucella 
abortus (102). We therefore tested the effect of light on SpxB activity. The H2O2 
concentration presents in supernatants of cultures grown microaerobically with or without 
ceiling lights was determined. Indeed, the H2O2 production was found to highly present 
with cultures in the flask under ambient laboratory lighting (Fig. 23). This suggested that 
light is required for H2O2 production.  
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Figure 23. Effect of light on the ability of DP1004 to produce H2O2. DP1004 cells were grown 
microaerobically in CATPGlu in a 13 mm slip cap test tube and a 125 ml flask, at 37˚C overnight. Samples 
were incubated in the dark incubator or under a light source. Supernatant from each was harvested for H2O2 
measurement. Mean values of duplicates from one independent experiment (±SE) are presented. N = 2. 
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We then demonstrated the connection between light and higher concentration of 
O2 in H2O2 production by determining the H2O2 concentration present in supernatants of 
cultures grown in a test tube of flask after vigorous shaking was supplemented. 
Surprisingly, the H2O2 concentration present in the flask without ceiling lights was 
restored in the presence of elevated O2, demonstrating no significant different to the 
counterpart (Fig. 24). Together, the data suggested that SpxB activity could be governed 
by O2 concentration and visible light while higher O2 concentration supplemented by 200 
r.p.m. shaking by-passed the need of light for H2O2 production. 
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Figure 24. Effect of light on the ability of DP1004, grown under aerated condition to produce H2O2. Cells 
were grown microaerobically in CATPGlu at 37˚C in a 125 ml flask and a 13 mm slip cap test tube. At 
OD550 ~ 0.2, vigorous shaking at 200 r.p.m was supplemented for both flask and tube samples for 1 hour, 
and either in the dark or under the ambient laboratory lighting. Supernatant from each sample was 
harvested for H2O2 measurement. Mean values of duplicates from one independent experiment (±SE) are 
presented. N = 2. 
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CHAPTER V 
 
 
CONCLUSION 
 
The presence of reactive oxygen compounds in facultative anaerobes is inevitable, 
especially in the bacterium S. pneumoniae that exists primarily in an aerobic 
environment. Despite that, higher H2O2 concentrations found in it, exhibits a novel 
characteristic of this catalase-negative microbe. In addition, current findings that (a) 
lactose induced H2O2 resistance in S. pneumoniae and (b) H2O2 resistance has an 
association with H2O2 production, extended the findings by Pericone (81). The aims of 
the present study involved (a) elucidation of the mechanism of lactose-regulated 
resistance to H2O2 and (b) determination of factors responsible for H2O2 production. 
These were explored by identifying the genes that are up-regulated by lactose as well as 
involved in H2O2 resistance and determining H2O2 concentrations by different conditions, 
respectively. In brief, our experimental findings are demonstrated below: 
 
First part, 
(1) The genes spr1639, ccpA, pyrB, and truB are involved in H2O2 resistance in S.  
pneumoniae. 
 
 73
Second part, 
(2) Mutations of spr1639, ccpA, pyrB, and truB do not have a defect in general 
cultural characteristics. 
(3) H2O2 resistance is positively correlated with H2O2 production in S. pneumoniae. 
(4) spxB operon is polycistronic.  
(5) Negative correlation of spxB activity with the expression of the gene was 
demonstrated simultaneously. 
(6) spxB activity is negatively correlated with the food availability. 
(7) spxB activity is positively correlated with the growth phase. 
(8) spxB activity is non-reversible after committement. 
(9) spxB activity is positively regulated by light. 
(10) spxB activity is up-regulated when cells are grown in a flask. 
(11) Light-dependence of spxB activity can be by-passed by aeration. 
 
Part I. Mechanism of H2O2 resistance in S. pneumoniae. 
 
Lactose pregrown cells exhibited higher resistance to H2O2 than any other sugars 
tested. This suggested that a lactose-induceable genetic pathway is involved in H2O2 
resistance. Indeed, there were genes up-regulated by lactose examined by growing cells 
on X-gal agar. However, only truB gene exhibited an increased expression in lactose 
compared to glucose. For unknown reason, trmE was not successfully cloned in E. coli. 
The function of this gene is suggested in E. coli to govern cell proliferation (115). The 
bgaA was not further studied here because it has been extensively studied and has been 
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experimentally shown to be involved in the lactose metabolism of S. pneumoniae (117). 
None of the genes found belong to any of the protein homologues known to be 
responsible for H2O2 resistance. Despite that, mutation of the genes led to decreased 
resistance to H2O2 while complementation restored H2O2 resistance in the mutants, only 
observed in DP1004 background. In fact, complementation of pyrB-deficient mutant 
showed approximately 2-fold higher resistance than the wild-type, further suggesting that 
pyrB was required for H2O2 resistance. In addition, this agreed with another finding that 
destruction of pyrB will result in a polar effect to its operon which rendering the cells a 
reduced oxidative stress (Fig. 27), demonstrating that S. pneumoniae pyrB operon (Fig. 
26) might have the same function as its close relative, Lactobacillus plantarum (Fig. 25, 
27) (44, 72). This suggested that there are at least two genes that are involved in H2O2 
resistance in the presence of lactose, and proposed question is answered.  
 
Mutation of ccp homologues spr1639 and sprr1813 caused H2O2 resistance to 
reduce in the mutants while complementation restored the resistance to H2O2 only in 
spr1813-deficient mutant, suggesting that spr1813 is involved in lactose-regulated H2O2 
resistance. This is consistent with another finding, demonstrating that spr1813 responds 
to lactose by up-regulating the bgaA of S. pneumoniae (56). In addition, regulation of 
pyrB by spr1813 was also suggested. Though no cre site could be detected within the 
promoter region of pyrB operon (44). The reason for failure to restore H2O2 resistance in 
spr1639-deficient mutant, which was previously shown to have at least 4-fold higher 
expression in lactose than in glucose, was not known. However, it could become another 
ccp of the bacterium that is involved in H2O2 resistance regulated by lactose.  
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Figure 26. Suggested pneumococcal pyr operon, NCBI (71). 
 
 
                               Figure 25. Illustration of pyrimidine and arginine biosynthesis in Lactobacillus           
                               plantarum (72). 
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Figure 27. Suggested interaction of H2O2 with NO (44). 
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Overall, our data in the first part of this study do not contradict with current 
findings, mentioned earlier, except, different results were observed when conditions vary. 
In addition, our data also added a possible factor of pathogenesis in S. pneumoniae. So, 
further work will be to study the mechanism of pathogenesis using sugar as one of the 
factors, hopefully, a more complete picture of the mechanism of pneumococcal 
pathogenesis will emerge. 
   
Part II. Mechanism of H2O2 production in S. pneumoniae. 
 
Different growth phases exhibited levels of H2O2 resistance independent of H2O2 
production, which was determined by growing cultures in a tube or flask. This finding 
suggested that growth phases can also govern H2O2 resistance. This is consistent with 
other findings where expression of every gene vary from phase to phase. This is shown in 
a pneumococcal gene expression profile, demonstrating that more house keeping genes 
are expressed as growth phases increase (62). An implication is that H2O2 resistance 
during stationary phase is governed by the bacterial detoxification mechanism (62, 98). 
We excluded the ability of mismatch repair which could have contributed to the 
resistance by repairing DNA damage from H2O2 because the strains we used were hexA 
null mutant (106).   
 
If S. pneumoniae has an increased resistance to H2O2 during stationary phase, one 
would expect its spxB expression to increase. In contrast, such correlation did not exist as 
demonstrated previously in two separate strains derived from Rx1. A similar observation 
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was found in the strain SP1625, which allowed the determination of both spxB expression 
and the enzyme activity, simultaneously. Both suggested that spxB expression does not 
correspond to H2O2 production. This agrees with the finding that demonstrates maximal 
spxB expression is present during early growth phase and H2O2 concentration is optimum 
during stationary phase when cells are grown microaerobically (7, 104). This further 
implied that there is another unknown genetic pathway governed by growth phase that is 
involved in H2O2 resistance.  
 
spr0643 was included in SP1625 construction because previous data demonstrated 
that it was essential for H2O2 production and arranged in the same transcriptional 
direction to its adjacent gene spxB. This suggested spxB operon is polycistronic. Co-
transcription of both genes examined by RT-PCR agreed with this finding, but, 
Pericone’s finding that spxB operon is monocistronic (determined by Northern blot 
analysis) (81). However, a spr0643-deficient mutant did not have a significant effect on 
the H2O2 production, conferring the gene’s function unknown at this point. A protein 
homolog has been found in E. coli, and it is involved in protecting an E. coli cell from 
oxidative stress (32). An H2O2 sensitivity test could be performed to determine the 
similar function demonstrated in E. coli. This could be carried out in S. pneumoniae, 
using spr0643-deficient mutant and comparing it with the wild-type to demonstrate the 
effect of complementation. Preliminary data demonstrated that spr0643 was likely to 
provide the cells protection against oxidative stress because mutation of the gene 
demonstrated high sensitivity to 10 mM H2O2 exposure (data not shown).  
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One of the reasons that explains no parallel relationship between spxB expression 
and the enzyme activity is that glucose represses the spxB activity, demonstrated as 
glucose was depleted, H2O2 production was activated (104). In addition, the pattern of 
spxB expression and enzyme activity can be explained by the involvement of spxB during 
competence in early growth phase, where competence is maximally present (7). If the 
first explaination is true, one would expect H2O2 production to reverse in the presence of 
fresh medium containing glucose because glucose inhibits H2O2 production. In contrast, 
H2O2 producing cells washed and grown in fresh medium did not lose H2O2 production. 
Despite that, onset of H2O2 production was found at the same growth phase, the 
stationary phase. 
 
We further explored the possibility that glucose represses H2O2 production by 
determining H2O2 concenration present in supernatants in cultures grown in other sugars. 
Overnight cultures produced normal H2O2 concentrations in all sugars except, fructose or 
galactose, which growth curves showed pneumococcal cells did not grow well in those 
sugars. This contradicted with Taniai’s finding that glucose represses H2O2 production 
(100). However, the data suggests that the glycolytic pathway is necessary for SpxB 
activity because all cells that showed normal H2O2 production undergo this pathway in 
the sugars tested. This is consistent with SpxB reaction, in that, it requires pyruvate, a 
product of glycolysis (81). This might have hindered the effect of different sugars on 
H2O2 production in overnight cultures because previous data suggested that increased 
H2O2 production should be found in cells pregrown with lactose. We therefore pursued an 
experiment to measure H2O2 concentration present in supernatants of cultures at various 
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growth phases. Indeed, cells pregrown with lactose started H2O2 production in early 
growth phase, and the H2O2 production was gradually incremented, with maximum H2O2 
concentration appearing during stationary phase. This was consistent with other finding 
that H2O2 resistance positively corresponds to H2O2 production, because previous data 
demonstrated higher H2O2 resistance cells pregrown with lactose (81). An implication is 
that lactose opens up another pathway of H2O2 production, but it is unknown whether that 
pathway also requires SpxB activity, because lactate oxidase is shown to function as 
another H2O2 producing agent in S. pneumoniae (104). 
 
If the other explaination is right, mutation of competence gene would allow early 
H2O2 production, but this is yet to be determined. A preliminary study demonstrated 
aeration caused reduction of competence and increased production of H2O2 (data not 
shown). Together, the data suggested a connection between O2, H2O2, and competence.  
Stationary phase-governed H2O2 production demonstrad previously in the presence of 
glucose, suggested the possibility that cell density regulates H2O2 production, so that, 
accumulation of cell density would activate H2O2 production. As expected, cell density 
equivalent to turbidity during stationary phase activated H2O2 production. In addition, 
one would also expect reversed H2O2 production from H2O2 producing cells when 
dilution is made. In contrast, dilution of H2O2 producing cells from stationary phase did 
not abolish H2O2 production. Together, the data implied that H2O2 production is cell-
density dependent and not reversible in H2O2 producing cells. In addition, another 
connection could also be established between high cell-density and H2O2 resistance, 
which is yet to be determined experimentally.  
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 A negative connection between quorum-sensing peptide and cell-density 
dependent H2O2 production was demonstrated by growing cells in supernatants from 
different growth phases followed by H2O2 measurement, because quorum-sensing peptide 
is commonly released from bacterial cells during high cell density (25). A similar finding, 
performed by aerating cells with or without proteinase K followed by H2O2 measurement, 
demonstrating that the culture did not have a defective in H2O2 production, further 
demonstrated that no quorum-sensing peptide was involved. However, involvement of 
non-peptide molecules presented on cell surface is possible in H2O2 production. 
 
 Different apparatuses, tube or flask, used to grow culture was found to lead to 
different concentrations of H2O2. This result suggested that variation in O2 concentration 
affects production of H2O2 by spxB. Indeed, normally, H2O2 production is activated 
simply by providing aeration that supplies an unknown concentration of O2. In addition, 
activation of H2O2 production in cells grown microaerobically in a flask during stationary 
phase may also relate to this. Together, the data suggested that certain concentration of 
H2O2 is required for SpxB activity to take place. An implication of that is certain O2 
concentration may contribute to different degrees of pneumococcal pathogenesis, since 
this pathogen is primarily found in an aerobic environment. 
 
 Culture of cells microaerobically grown in a flask under ambient light activated 
H2O2 production. This suggested that light is required for spxB activity. This agreed with 
other finding that flavin-composed proteins are activated by light because SpxB is 
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composed of flavin (86, 102). A continuous study of light-dependent H2O2 production 
will determine the exact wavelength for the SpxB activation. 
 
Lastly, aerated cells grown in a flask under ambient light exhibited similar 
concentration of H2O2 to the one without light. This suggested that higher O2 
concentration abolishes the light-mediated mechanism (still unknown) that is involved in 
H2O2 production. Together, the data implied that there is an unknown association 
between light and O2 by which either both or O2 is required for H2O2 production. 
 
Overall, we showed that H2O2 production is not the only factor that offers a 
protection against H2O2 insult. We found that, resistance to H2O2 could also be activated 
as cell-density increases gradually. In addition, role of light in H2O2 production may also 
suggest to us another possible connection between H2O2 production and the resistance to 
H2O2 when light is present.  
 
In summary, S. pneumoniae acquires ways to protect itself from oxidative stress 
caused by the environment the bacterium lives in, which is O2-rich, and to be viable to 
perform pathogenesis at the degree similar to the condition that is favorable to it. 
Through the discovery of the connection between O2, sugar, and light in virulence of S. 
pneumoniae, one can also apply the findings to other lactic acid bacteria to further 
disclose hindered capabilities of bacteria. 
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